When was Aethl Bio founded?

Aethl Bio was founded in 2025 and raised its 1st funding round within a year of its incorporation.

Where is Aethl Bio located?

Aethl Bio is headquartered in Pittsburgh, United States.

Is Aethl Bio a funded company?

Aethl Bio is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Jul 14, 2025.

When was the latest funding round of Aethl Bio?

Aethl Bio's latest funding was a $***** Seed round on Jul 14, 2025, with participation from 0 investor.

Where does Aethl Bio rank among its competitors?

Aethl Bio ranks 182nd amongst 205 active competitors, of which 46 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Tissue Regenix, which secured $10.1M in Dec, 2025.

Who are the top competitors of Aethl Bio?

Aethl Bio's top competitors include SolasCure, SanuWave and Nuo Therapeutics. Among them, Tissue Regenix secured the most recent funding round in December, 2025.

Aethl Bio - 2026 Company Profile, Funding & Competitors

Company Details

Developer of medical products for treating chronic skin wound conditions. These products focus on restoring skin function and integrity to facilitate healing. The technology addresses underlying biological factors to reduce complications and recurrence associated with non-healing wounds. The development process incorporates research in wound biology to create therapeutic applications for clinical use.

Website: aethl.com
Social
Email ID: *****@aethl.com
Phone Number: +1 **********

Key Metrics

Founded Year

2025

Location

Pittsburgh, United States

Stage

Seed

Total Funding

$1.63M in 1 round

Latest Funding Round

Seed, Jul 14, 2025, $*****

Ranked

182^nd among 205 active competitors

Similar Companies

SolasCure & 238 more

View Aethl Bio's full profile

Aethl Bio has raised a total funding of $1.63M over 1 round.

Here is the list of recent funding rounds of Aethl Bio:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 14, 2025	8151509	Seed	1266530	9433402	8580105	8320998

Access funding benchmarks and valuations. Sign up today!

View details of Aethl Bio's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Aethl Bio include SolasCure, SanuWave and Nuo Therapeutics. Here is the list of Top 10 competitors of Aethl Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	SolasCure 2017, Cambridge (United Kingdom), Series B	Transforming chronic wound care	$34.1M	Seneca, Tricor Group & 66 others	62/100
2nd	SanuWave 2005, Alpharetta (United States), Public	Developer of Noninvasive devices, and biologics for wound healing	$1.43M	CIT, Kingswood Capital Markets	60/100
3rd	Nuo Therapeutics 2001, Gaithersburg (United States), Public	Developer of regenerative products for wound care	$69.1M	MidCap Financial, Maryland Department of Commerce ... & 2 others	58/100
4th	Sanara MedTech 1982, Fort Worth (United States), Public	Developer of therapeutics for infectious disease	-	BlueIO, The Catalyst Group	56/100
5th	TargED 2020, Utrecht (Netherlands), Series A	Developer of biological drugs for the treatment of thrombosis	$82.8M	Hadean Ventures, Inkef & 8 others	56/100
6th	MediWound 2001, Yavne (Israel), Public	Developer of enzymatic therapeutic solutions for tissue repair and regeneration	$18M	Point72, aMoon & 10 others	54/100
7th	Tissue Regenix 2006, Swillington (United Kingdom), Public	Developer of regenerative medical devices by using cell technology	-	Harwood Capital, IP Group & 2 others	53/100
8th	QBiotics 2000, Brisbane (Australia), Series C	Developer of small molecules discovered from the plant extracts	$98.1M	TDM Growth Partners, WG Partners	53/100
9th	Next Science 2012, Jacksonville (United States), Public	Redefining healing through science, innovation, and commitment to better patient outcomes	-	-	51/100
10th	BioStem Technologies 2006, Pompano Beach (United States), Public	Provider of placental-based amniotic tissue products	-	-	51/100
182nd	Aethl Bio 2025, Pittsburgh (United States), Seed	Developer of medical products for treating chronic skin wound conditions	$1.63M	-	20/100